IL4 and Alzheimer disease: Conversely, in AD, the emergence of psoriasis or psoriasiform eruptions has been reported, most notably with dupilumab, an IL-4/IL-13 inhibitor, and more recently with tralokinumab, a selective IL-13 inhibitor.2